Navigation Links
Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
Date:6/26/2012

New York City, NY (PRWEB) June 26, 2012

The Actos Resource Center, a patient advocacy group, is alerting patients who suffered injury after taking the diabetes drug Actos that certain Statutes of Limitation in their state could limit the amount of time they have to file a claim.

Anyone who has been diagnosed with bladder cancer or heart disease after taking the drug should consult with their doctor and contact a lawyer to learn about their legal options.

A little over a year ago on June 15, 2011, the FDA warned that Actos may be associated with a higher risk of bladder cancer. According to The Canadian Press on April 19, 2012, Health Canada joined the U.S., France, Germany and the European Medicines Agency in also issuing an Actos bladder cancer warning.

Hundreds of people have now contacted the Actos Resource Center to learn about their legal options after suffering bladder cancer, heart attacks or liver damage.

According to a Bloomberg report, Takeda faces thousands of Actos lawsuits from patients in the U.S. In an article published March 13, 2012, the news agency predicted as many as 10,000 patients may eventually file an Actos bladder cancer lawsuit.

However, victims who were prescribed Actos in a state with a one-year statute of limitations could face added legal challenges. According to lawyers with the Actos Resource Center, attorneys for Takeda Pharmaceuticals will likely argue that the deadline for victims in these states started on June 15, 2011 with the FDA warning and should expire a year later.

So far, no court has indicated that such cases would be barred, and a qualified lawyer can advise how long victims have to take action. However, since each case has a different expiration date, anyone affected is urged to seek help as soon as possible.

In December, a federal Judicial Panel on Multidistrict Litigation issued an order consolidating all lawsuits to a federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette)

The Actos Bladder Cancer Center only works with Actos lawyers who are actively involved in this litigation and have handled thousands of cases.

For more information on the research, actos warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit http://www.ActosCancer.com.

Read the full story at http://www.prweb.com/releases/actos-bladder/cancer-lawsuit/prweb9640081.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
2. Brain-Injury Recovery Varies Widely Among Children
3. Substance Abusers, Even Recovering Ones, May Face Stigma
4. Recovery from propofol anesthesia may be sped by use of common stimulant
5. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
6. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Study Ties Secondhand Smoke to Bladder Irritation in Kids
9. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
10. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
11. Chemo + Radiation Best for Bladder Cancer, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: